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ata  Protection Act
a  b  s  t  r  a  c  t
Ethics,  an  essential  dimension  of  human  research,  is considered  both  as discipline  and
practice.  For  clinical  research,  ethically  justiﬁed  criteria  for the design,  conduct,  and  review
of clinical  investigation  can  be identiﬁed  by obligations  to both  the  researcher  and human
subject.  Informed  consent,  conﬁdentiality,  privacy,  privileged  communication,  and  respect
and responsibility  are  key  elements  of ethics  in  research.  A  systematic  literature  search  of
English-language  articles  on Medline,  ISI  web  of knowledge,  Sciencedirect,  Google  scholar,
the Cochrane  database  of  evidence-based  reviews,  and  the Database  of Abstracts  of Reviews
of Effects  was  performed  by connecting  the  Mesh  terms  (“ethics”,  “medical  research”,
research  ethics”,  “medical  education”,  “research  ethics  principles”.  The  abstracts  of  461
articles were  reviewed  for  the  relevancy  of topic  and  analyzed  in terms  of application  and
validity.  Out  of  these,  21 studies  were  found  relevant  as  they  concentrated  principles  of
ethics  in medical  research,  their practical  applications,  and  suggested  guidelines  for  future
research.
Research ethics  committees  must  promote  greater  understanding  of  ethical  issues  on
biomedical  research.  These  committees  function  for submission,  consideration,  evalua-
tion, and  communication  of  ﬁndings.  Application,  research  protocol,  patient  information
leaﬂet  and  informed  consent  form,  and  any  other  supporting  documentation  are  thoroughly
reviewed  by  research  ethics  committees  for legal  and  moral  safety,  integrity,  and welfare
of the  research  subjects.
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and  consent.
In  the next two  decades following Nuremberg Code,
sporadic uses of prior review processes was  implemented,
but the prevailing view was  that reliance on the primary
Table 1
Statements of Nuremberg Code [14].
No. Statements
1 Voluntary consent to be based on sufﬁcient knowledge
of  the nature, duration, purpose, methods,
inconveniences, hazards, and effects of the research
2 Research would yield fruitful results for the good of
society  not procurable by other methods
3  Research to be based on animal research and prior
knowledge
4 All unnecessary physical or mental suffering and injury
to  be avoided
5 No experiment be conducted in which death or
disabling injury will occur (except where physicians
were also subjects)
6 Degree of risk would not exceed that determined by
the  humanitarian importance of the problem to be
solved
7 Preparation and facilities be provided to protect
subjects against even the remote possibility of injury,
disability, or death
8 The research be conducted by scientiﬁcally qualiﬁed
persons and require the highest degree of skills and
care
9 Subjects be free to bring an experiment to an end if
they  reached the physical or mental state whereReferences .  .  . . . .  .  .  . . . .  . . .  . . . . . . . . . . . .  . . . .  . . .  .  .  . .  .  . . .  .  . . .  . . .  .  
1. Historical background
In  the early 1960s, most notably in the United States,
instances of unethical medical research was reported over
the  volunteers, especially those who were vulnerable or
terminally sick, were treated with obvious disrespect and
exposed  to signiﬁcant risks of harm [1]. Among these were
the  infamous project conducted at the Brooklyn Jewish
Chronic Disease Hospital in which elderly patients who
had  some disability were injected with live cancer cells
in  circumstances in which it was unclear whether con-
sent  was sought [2]. A study of infectious hepatitis C at
the  Willowbrook home for children with mental retarda-
tion,  who were deliberately infected with hepatitis C, not
only  raised serious concerns in public, but also jeopardized
the reputation of noble medical profession. In 1966, Henry
Beecher’s article, ‘Ethics and Clinical Research,’ in the New
England  Journal of Medicine reported 22 examples of med-
ical  research that involved suboptimal ethical treatment of
human  subjects [3]. For nearly 40 years (1932–1972), the
U.S.  National Health Service conducted a research titled the
‘Tuskegee  Study of Untreated Syphilis in the Negro Male.’
The  study was done on about 600 black men, of whom 399
had  syphilis. The participants were never informed that
they  were involved in a research study, and their informed
consent was not obtained [4]. Such unethical incidents
necessitated the dire need of informed consent from par-
ticipants and researchers’ responsibility to be satisﬁed that
the  gain anticipated in any research project was  commen-
surate with the risks involved.
This article explicitly reviews widely accepted ethi-
cal  principles that govern the conduct of research with
human participants. Application of research ethics com-
mittees  to monitor and approve prior review of proposed
research that involves human participants or subjects
(human research) has been elucidated along with the legal
and  practical implications.
2.  Research ethic’s declarations and treaties
A number of treaties and declarations have been
reported in the literature, which addressed fundamental
principles of ethical conduct in biomedical research: the
Nuremberg Code [5], the Declaration of Helsinki [6], EU
Convention on Human Rights and Biomedicine [7] Con-
vention on Human Rights and Biomedicine (the Oviedo
Convention) [8] various guidelines promulgated by the
Council  for International Organizations of Medical Sciences .  .  . . .  . . .  .  . .  . . .  .  . . .  . . .  . .  .  . . . . .  . .  . .  . . . . .  .  . .  . . . .  .  . . . .  . .  .  .  .  . .  .  .  . . .  .  125
[9],  and a number of treaties and conventions [10–13]. Prin-
ciples  have been enunciated speciﬁcally to protect human
subjects from harm and to demonstrate respect for their
autonomy. The two comprehensive and pioneering docu-
ments  about research ethical issues are considered to be
the  Nuremberg Code and the Declaration of Helsinki.
2.1. Nuremberg Code (1947)
In the nineteenth century, the judgment of the trial of
the  Nazi doctors at Nuremberg is the commonly recognized
starting event for modern research ethics. It contained ten
paragraphs, referred to as the Nuremberg Code [5], out-
lined  in Table 1. In the modern world, this is regarded as
the  founding document of contemporary research ethics,
which  emphasizes on sound scientiﬁc research protocolcontinuance seemed impossible
10 Researchers be prepared to terminate the experiment
if  they had cause to believe, in their good faith, skill,
and  judgment, that continuation was  likely to result in
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esponsibility of researchers in the design and conduct of
edical  research offered ample protection of the involved
articipants.
.2.  Declaration of Helsinki (1964)
In 1964, the Declaration of Helsinki, published by the
orld Medical Association (WMA), introduced an author-
tative  attestation of the need for prior review of any kind
f  human research [6]. Although the Declaration empha-
ized the scientiﬁc standards that should govern scholarly
esearch, it allowed more freedom to the physicians to omit
he  application of consent procedures in special circum-
tances [15]. This shortcoming of the Declaration indicated
hat  the rights and safety of the research participants still
ied  with the individual investigator. Then came the revi-
ion  of the Declaration of Helsinki in 1975 [16] that required
he  assessment of research protocols by an independent
esearch ethics committee. With the revised version, it
eemed  that biomedical research involving human sub-
ects  ﬁnally had been furnished with a ﬁrm system of
nternationally accepted norms and principles [17]. Today,
he  Declaration of Helsinki is considered as a document of
thical  principles for medical research involving human
ubjects, including research on identiﬁable human material
nd  data.
.  Research ethics committees
The  system of prior ethical review of medical research
mploys to protect the rights and welfare of human partic-
pants,  ensuring the legal and ethical application of codes
f  practice of medical research conduct. US federal regula-
ions  for the protection of human research subjects deﬁne
 “human subject” as “a living individual about whom
n  investigator obtains [1] data through intervention or
nteraction with the individual, or [2] identiﬁable private
nformation” [18].
An  institution’s Research Ethics Committee (REC) aims
o  safeguard the welfare, dignity, and safety of the par-
icipants, ensures that ethically approved research is
onducted in line with the approved protocol, and pro-
otes  public conﬁdence in the conduct of human research.
ECs  play key roles in promoting ethical practices in
iomedical research and in identifying solutions to ensure
hat  the interests of researchers and society do not take
recedence over the rights of the participants [19].
The  committee performs the following functions [20]:
a.  Prior review of human research proposals, scrutiniz-
ing the ethical standards for research conduct in legal
framework
. Observations to the investigators, to modify the
research proposal to meet the required ethical standardsc.  Decision to approve or reject the research proposal
. Monitoring the conduct of approved research proposals,
ensuring that their conduct continues to conform to the
approved protocold Ultrastructure 2 (2014) 121–126 123
e. Resolution, or referral for resolution, of complaints in
relation to the conduct of approved research projects or
the conduct of the ethical review of those projects
f. Premature termination and/or suspension of the con-
duct of a research proposal whenever it becomes evident
that continuing conduct will expose participants to
greater levels of risk than those approved
g.  Accountability and quality assurance by reporting to
the relevant institution about its performance
Applications to the RECs follow the ofﬁcial review of the
proposal, and one of the following decisions may  be sought:
1.  Accept without changes
2. Accept with suggested changes
3.  Recommend submission to committee of another region
4.  Revise and resubmit (with changes)
5.  Reject (with reasons)
4. Research misconduct
Currently,  majority of the research misconduct and
irregularities are related to studies funded by the phar-
maceutical industry and strongly linked with the ﬁnancial
interests of this industry. Technical faults in the research
design, wrong recruitment process, insufﬁcient sample
size,  and weak statistical analysis of the data often lead to
non-publishable research. Another form of research mis-
conduct  is the procedural irregularities by misinterpreting
the trial data, attempting to draw favorable conclusions
than those warranted by the available data [21]. Repor-
ting  of fabricated favorable results due to the comparison
of the drug under study only against placebo or a non-gold
standard drug also leads to research misconduct.
5. Key issues of research ethics
5.1. Informed consent
Informed  consent refers to an ethical and legal doc-
trine based on the understanding that all interventions
(diagnostic, therapeutic, preventive, or related to scientiﬁc
studies) in the medical ﬁeld should only be performed after
a  participant has been informed about the purpose, nature,
consequences, and risks of the intervention and has freely
consented to it [22]. The primary focus of consent should
be  on informing and protecting research subjects, through
disclosure and discussion of relevant information, mean-
ingful  efforts to promote participants’ understanding, and
by  ensuring that decisions to participate, or to continue
participating, are always made voluntarily.
Informed consent is the ethical cornerstone of random-
ized clinical trials (RCT), where volunteers are given the
option  to participate in a trial that includes randomiza-
tion or to remain outside the trial and receive traditional
medical treatment. Mandatory condition for an informed
consent include; provision of detailed information to a sub-
ject;  adequate understanding of the information provided;
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The researcher’s primary moral responsibility is to
design a clinical trial that will answer a research question
without exposing human subjects to undue risks in the pro-
cess  [24]. When fully informed subjects give their consent,
acknowledge their role as research participants and take
responsibility for their designated roles. Assuming that the
research  question is signiﬁcant, the trial is well structured,
and the risks to the individual patient are justiﬁed, the
tension between collective ethics and individual ethics is
obviated  when individual subjects give their informed con-
sent.  This holds true if the primary intent of the investigator
is  to compare two treatments, not to provide better overall
care  to the subject [25]. Implementation of informed con-
sent  can be considered as a sign of the growing patients’
welfare and rights movement, protecting various dimen-
sions  of their integrity, safety, and conﬁdentiality.
Obtaining consent does not necessarily employ disclos-
ing  the information; rather it demands comprehension of
the  information ensuring that the subject is, in fact, ami-
cably  informed. However the problems in attaining fully
informed consent are well documented [26,27]. In some sit-
uations,  despite researcher’s sincere efforts, subjects often
fail  to understand the nature or rationale for the research
and hence are incapable of providing an informed consent.
In  two separate studies that assessed biobank partici-
pants’ understanding, more than one-third of participants
answered questions incorrectly regarding the objective of
the  research, limitations to conﬁdentiality protections, that
their  DNA would be stored as part of the research, that
the  research involved some risks, and whether they would
receive  individual genetic results [28,29]. This reﬂects an
important  understanding that genomic research presents
challenges for traditional models of informed consent, and
provides  opportunities for new models of consent and com-
munication [30].
5.2.  Patient information sheet
Once informed consent is obtained, the research sub-
ject  is given a patient information sheet [31], detailing the
following  aspects of the study:
1. Title of the research project
2. Invitation to participate in the research
3.  Purpose and signiﬁcance of research
4.  Time commitments
5. Termination of participation, indication voluntary con-
tribution
6. Risks involved
7. Costs and compensation
8. Anonymity and conﬁdentiality
5.3. Conﬁdentiality
Conﬁdentiality means the nondisclosure of certain
information except to another authorized person. The con-
cept  of conﬁdentiality applies that the information a person
reveals  to a professional is private and has limits on how
and  when it can be disclosed to a third party [32]. Various
dimensions of conﬁdentiality described in the literature
include human rights, conﬁdentiality in young persons,d Ultrastructure 2 (2014) 121–126
domestic violence, true anonymisation of data, validity of
consent  for disclosure, cancer and genetic registers, fertil-
ity,  involuntary disclosure, and safeguards [33].
There is no breach of conﬁdentiality if the following
recordings for any purpose were used, as long as they were
effectively anonymised [34]:
a. Conventional X-rays
. Images taken from pathology slides
c.  Laparoscopic images of the inside of abdominal cavity
. Images of internal organs
e. Ultrasound images
To maintain the subject conﬁdentiality, the researcher
should collect only the data that is really required, should
collect anonymous data, store name and data separately by
using  identiﬁcation numbers instead of names, use pass-
word  to protect the data ﬁles, and secure the ofﬁce and
computer.
5.4.  Privacy
Privacy is the quality of being secluded from the pres-
ence  or view of others. Privacy in research refers to the
right  of an individual to make decisions concerning how
much  information about their physical status, health, social
network,  and thoughts and feelings will be shared with
investigators [35]. To protect the privacy rights of fam-
ily  members, researchers must be careful in determining
whether family members should be considered as research
participants.
5.5.  Privileged communication
Privileged  communication includes conversations
within the context of a protected relationship, such as
that  between doctor and patient, a therapist and client, an
attorney  and client, a husband and wife, or a priest and
penitent; under common law, privilege involves a number
of  rules excluding evidence that would be adverse to a
fundamental principle or relationship if it were disclosed
[36]. Such communications are secure, reliable, and meant
to  be kept among the directly involved parties.
5.6. Respect and responsibility
Respect  in research refers to respect for people and
respect for truth. People have the right to dignity and pri-
vacy  (informed consent and conﬁdentiality). Respect for
truth  implies probity and respect for the intellectual rights
of  others. All possible efforts should be directed to avoid
plagiarism and clinching false conclusions by over and
under  emphasizing the results [37].
Responsibility of the human subject involves volun-
tary informed consent, avoiding deception, rewards and
incentives, privacy, and disclosure. Also the researchers are
responsible  for maintaining the reputation of educational
research by adhering to the highest standards of qual-
ity  research. When publishing the research, investigators
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. Data Protection Act 1998
This act is applicable to the researchers residing in the
K  and explicitly describes the legal ways and means to use
he  personal data. Brieﬂy, the act can be viewed as having
 standards outlined in Table 2.
.1. Overview of research ethics in medical education
Medical research ethics is anchored in the Hippocratic
ath, in doing no harm, and tends to take the protec-
ion of the individual as its main objective [38]. Therefore,
ccording to the Declaration of Helsinki, studies should be
esigned  in the safest manner possible and every medi-
al  research project involving human subjects should be
receded  by careful assessment of predictable risks and
urdens weighed against foreseeable beneﬁts to the sub-
ect  or to others.
General principles governing the ethics in research
emand that research involving humans has merit and is
eneﬁcial,  that researchers have integrity, that the bene-
ts  and burdens of research participation are justly shared,
hat  risks to participants are minimized and are justiﬁed
y  potential beneﬁts, and that participants are respected
s  people and their informed consent is given [1]. Recently,
here  is escalating attention to topics such as reasons for
r  against participants’ satisfaction with informed con-
ent  procedures [39], comprehension of risks [40], views
n  compensation [41] and sources of trust or mistrust in
he  research enterprise [42]. Punch [43] challenged that
he  process of obtaining informed consent is inappropri-




•  The research subject must be informed that who  will
hold the data, who will have access to data and the
reason  for holding the data
• If the data is collected from a third party e.g.
physicians,  then they must be informed about the
research
•  Researchers must review the need to hold personal
data
2
•  The data should only be collected for the deﬁned
objective(s)  and should not be further processed which
is  not consistent with the objective
• An exception to this statement being the recycling of
the personal data in a manner that it would not inﬂict
damage or distress to the research subjects
3  The data must be only that which is required for the
designed research
4 The data must be accurate and if necessary updated
5
•  The data must not be maintained unnecessary longer
than the planned research
•  An exception to this statement being the recycling of
the personal data in a manner that it would not inﬂict
damage or distress to the research subjects
6  Empowers the research subjects with the right to
know  what data is kept about them, the reasons for
keeping  the data, who will be told about the data, and
purpose  of this exercise
7 Data should be stored securely. Computer ﬁles should
be  password controlled and manual ﬁles should be
secured  in locked containersd Ultrastructure 2 (2014) 121–126 125
place, even though the mere presence of a researcher does
change  the situation. This is known as the “observer’s para-
dox.”  Also psychiatric patients are not wholly free to choose
when  it comes to activities such as leaving the hospital,
and cannot choose when visitors enter or leave the ward
(these  are some reasons for regarding this group as vul-
nerable) [44]. Hence, ethical guidelines, such as informed
consent, the principle of voluntariness, and estimating
the risk/beneﬁt ratio, become substantial challenges when
employed in special circumstances.
6.2.  Future vision and research potential
There are certain areas in research ethics, which need
further investigations and analysis. Salient features are
highlighted below:
1.  There should be a consensus on the right to withdraw
by the researcher. Due to the danger of rapid dissemi-
nation, this right to withdraw becomes impractical and
invalid in no time, and current recommendations do not
have enough regulatory control in such situations.
2.  There is an urge for a fundamental and precise
risk/beneﬁt  analysis of the public data sharing.
3. The existing and emerging governance structures and
guidelines need to be explored and researched. This will
facilitate the utility and constructive use of technologies
within ethical frameworks.
4. The institutions need to organize workshops, semi-
nars, and training courses for the academia and novice
researchers for the education and knowledge about
research ethics.
6.3. Conclusion
Ethics of medical research on human subjects must be
clinically justiﬁed and scientiﬁcally sound. Informed con-
sent  is a mandatory component of any clinical research.
Investigators are obligated to design research protocols
that establish standards of scientiﬁc integrity, safeguard
ethical and legislative issues of the human subjects, and
follow  the protocols for prospective review by independent
research ethics committees.
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